Opendata, web and dolomites

LPPDS

A portable peritoneal dialysis system for home use that monitors for infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LPPDS project word cloud

Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.

peristaltic    pump    human    53    either    times    diabetes    issue    home    core    patent    seeing    end    share    kidneys    economic    health    ease    catheters    requiring    filtering    liberdi    ckd    doctors    monitoring    socio    adherence    sufficiently    prevalence    hospitals    decline    function    exchange    travel    sterile    renal    peritoneal    population    stage    minutes    disease    west    plans    revolutionises    adding    dialysis    flow    fifth    centres    lightweight    obesity    public    day    disposable    kidney    transplant    patients    errors    schedules    last    carry    complexity    session    protocol    week    travelling    blood    hours    consists    calculate    portable    inhibit    eskd    esrd    ux    epidemics    hd    pending    designed    recognised    doctor    connectors    waste    chronic    caused    external    correct    pd    choosing    hypertension    longer    market    takes    patient    offerings    rate    difficult    lppds    globally    truly    compliance    occurs    aging    device    decreasing    treatment    fluid    poorer    reduce    automation    efficacy    time    latter    smart    holds    saving    haemodialysis    speeds   

Project "LPPDS" data sheet

The following table provides information about the project.

Coordinator
LIBERDI LTD 

Organization address
address: 17 T'CHELET STREET
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.liberdi.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIBERDI LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.

The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.

liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More